'Dimmer switch' medicines: a revolution in treatment with fewer side effects
17 November, 2016By targeting previously unappreciated drug recognition sites in the body, a new class of medicine is on the horizon that will effectively treat chronic conditions while being selective enough to eliminate side effects.
Needle-free vaccine delivery wins Young Florey Medal
10 November, 2016 by Adam FloranceProfessor Mark Kendall has been awarded the 2016 CSL Young Florey Medal for inventing a vaccine delivery system that is painless, efficient and eliminates the need for refrigeration.
Opinion: R&D tax incentives are critical to Australia's innovation economy
09 November, 2016 by Dr Cameron Ferris, Commercialisation Manager, The iQ Group GlobalThe iQ Group Global recently made a submission in response to the review of the R&D Tax Incentive released by the Minister for Industry, Innovation and Science, Greg Hunt.
Open source: the future of malaria medicines
01 November, 2016To help tackle the major health problem of malaria, a unique 'open source' study led by researchers at the University of Sydney has established a collaborative patent-free environment that is expected to accelerate the development of new malaria treatments.
Four days, three events: International BioFest 2016
27 October, 2016 by Lauren DavisToday is the last day of International BioFest — a series of three major life sciences conferences taking place over the one week.
Could crab shells enhance wound healing?
25 October, 2016Different nanomaterials are being tested in combination with chitosan — a sugar derived from crab and shrimp shells — for applications in the biomedical field. If the tests are successful, they could lead to breakthrough such as enhanced bone regeneration, improved wound healing and targeted drug delivery.
A financial boost for the MTP sector
25 October, 2016MTPConnect, the MedTech and Pharma Growth Centre, has announced $7.4 million in funding over two years for 14 national projects in the medtech, biotech and pharmaceutical (MTP) sector.
Bronchial valve system for severe emphysema
20 October, 2016Olympus has announced positive results from a multicentre study assessing the safety and effectiveness of its endobronchial therapy for severe emphysema.
Treating asthma with stem cells
17 October, 2016Cynata Therapeutics has received positive data from a proof-of-concept study of its Cymerus mesenchymal stem cells (MSCs) in an experimental model of asthma.
Epilepsy drug now available for tonic-clonic seizures
13 October, 2016Fycompa, a once-daily epilepsy treatment, is now available in Australia for adjunctive treatment of primary generalised tonic-clonic (PGTC) seizures in adults and adolescents with idiopathic generalised epilepsy.
International BioFest 2016 is coming to Melbourne
12 October, 2016From 24–27 October 2016, Melbourne Convention Centre will play host to International BioFest — a series of three major life sciences conferences taking place at the one time.
New venture capital fund for Australian healthcare start-ups
11 October, 2016BioScience Managers has announced the launch of a new venture capital fund for Australia's innovative healthcare and biomedical research sectors.
A potent antioxidant from apples and water
10 October, 2016A scientist from the University of Newcastle has developed what is claimed to be the most potent dietary antioxidant available anywhere in the world.
Peanut allergy treatment gets a $15 million boost
06 October, 2016OneVentures will lead a $15 million funding round for a promising new treatment for peanut allergy in children, developed at the Murdoch Childrens Research Institute.
Titratable sleep apnoea device cleared by FDA
28 September, 2016Oventus Medical has received clearance from the US FDA for the O2Vent T device, an oral appliance intended to alleviate snoring and obstructive sleep apnoea.
